- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 7.12M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $23.38K |
| Capex | Q1 2025 · Mar 31, 2024 | $5.04K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $769.26K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $876.98K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $769.26K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $885.09K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.5M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.85M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.67M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.08M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 6.48M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$892.09K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.36M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.55M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.20 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.20 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $512.24K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $343.28K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.32M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.21M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $90.3K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $89.21K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $179.51K |